Korea’s Samsung Partners With UCSF To Verify, Innovate mHealth
This article was originally published in PharmAsia News
Korea’s Samsung Electronics and the University of California, San Francisco’s Center for Digital Health Innovation are teaming up to verify and validate digital health products. The collaboration will also attempt to bring new products to market.
You may also be interested in...
Startup Gelesis Inc. announced a $12 million funding round to support an FDA study for its Gelesis 100 “smart pill” as a tool to induce feelings of hunger and satiety.
McKesson Corp.’s McKesson Anesthesia Care clinical decision support system was the subject of a class I recall, a rarity in the health information technology sector that could offer insights into FDA oversight of the space going forward.
Recent activities by three smartphone giants point to a potential future where the phone itself more frequently serves as a monitoring or diagnosing device, in place of external sensors. If the trend rolls on, it could have important implications for the mobile health sector.